Eisai Will Also Co-Develop Alzheimer Drug In Japan With Biogen
This article was originally published in PharmAsia News
Executive Summary
Eisai and American Biogen Idec have decided to co-develop and co-promote two Alzheimer’s drugs in Japan, the Japanese company announced on May 9.